top of page

The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.

About the study

NCT Trial Number

NCT04433845

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Sheppard Pratt Health System
COMPASS Pathways

noun_date_3237048.png

Trial Start Date

Jul-20

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

​

Eyes Graffiti

Locations

United States, Maryland
Sheppard Pratt Health System
Baltimore, Maryland, United States, 21204

Contact: Kelsie Kaier
4109383126
kkaier@sheppardpratt.org

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page